Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector.
These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule.
Affilogic has designed Nanofitins® against 60+ targets to date, including a wide range of circulating antigens (peptides, proteins), membrane receptors for inhibition / modulation (GPCR, ion channels) and complex entities (virus-like particles, bacteria, whole cells).
Company Details
- Employees
- 37
- Founded
- -
- Address
- 24, Rue De La Rainière, Nantes,pays De La Loire 44300,france
- ol****@****gic.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- affilogic.com
- HQ
- Nantes, Pays de la Loire
Affilogic Questions
Affilogic's website is affilogic.com
Affilogic's LinkedIn profile is https://fr.linkedin.com/company/affilogic
Affilogic has
37 employees.
View email and phone details for 37
employees at Affilogic.
Affilogic's industry is
Biotechnology Research
Affilogic's top competitors are
Valneva,
Clean Cells,
Gliocure,
Naobios,
Naogen Pharma,
Xenothera,
Goliver Therapeutics,
Chelatec,
Atlanthera,
Ose Immunotherapeutics.
Affilogic's support email address is olivier@affilogic.com
Affilogic's categories are Biotechnology Research
Affilogic's founding year is 2010
